| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 08/03/2006 | WO2006015371A3 Humanized anti-cmet antagonists |
| 08/03/2006 | WO2005116655A3 Natriuretic compounds, conjugates, and uses thereof |
| 08/03/2006 | WO2005110470A3 Methods and compositions for the modulation of immune responses and autoimmune diseases by activating rp105 (cd180) |
| 08/03/2006 | WO2005110452A3 MULTIPLE-VARIABLE DOSE REGIMEN FOR TREATING TNFα-RELATED DISORDERS |
| 08/03/2006 | WO2005108428A3 Cd40 splice variants and their uses |
| 08/03/2006 | WO2005089808A3 Antibody calicheamicin conjugates |
| 08/03/2006 | WO2005085288A3 Natural igm antibodies and inhibitors thereof |
| 08/03/2006 | WO2005076958A3 Methods of determining the prognosis and treatment of subjects with pin 1 associated disorders |
| 08/03/2006 | WO2005049651A3 Cancer diagnosis and therapy |
| 08/03/2006 | WO2005041862A3 Neutralizing antibodies against extracellular hexosaminidase for treatment of arthritis |
| 08/03/2006 | WO2004058171A3 Antibodies against gpr64 and uses thereof |
| 08/03/2006 | WO2004050838A3 Plant production of immunoglobulins with reduced fucosylation |
| 08/03/2006 | WO2004039951A3 Il-1 receptor based antagonists and methods of making and using |
| 08/03/2006 | WO2004034974A3 Anti-reg iϝ antibody for treatment of colon cancer |
| 08/03/2006 | WO2004001381A8 Novel raag10 cell surface target and a family of antibodies recognizing that target |
| 08/03/2006 | WO2002102319A3 Polynucleotide encoding a novel human growth factor with homology to epidermal growth factor, bgs-8, expressed highly in immune tissue |
| 08/03/2006 | US20060173171 Techniques and compositions for diagnosis and treatment of cancer (muci) |
| 08/03/2006 | US20060173170 Fc variants with altered binding to FcRn |
| 08/03/2006 | US20060172933 Natriuretic compounds, conjugates, and uses thereof |
| 08/03/2006 | US20060172921 Method for identifying active anti-apoptosis compounds |
| 08/03/2006 | US20060172386 Human FGF-20 gene and gene expression products |
| 08/03/2006 | US20060172382 Selection of host cells expressing protein at high levels |
| 08/03/2006 | US20060172374 Phosphorylated ndr kinase |
| 08/03/2006 | US20060172358 Novel chemiluminescent compounds and their use |
| 08/03/2006 | US20060172356 include immunogenic moieties that can be used to prepare anti-lamotrigine antibodies, or antigenic moieties; antiepileptic drug, bipolar diseases; kits |
| 08/03/2006 | US20060172355 Novel proteins in enteroaggregative Escherichia coli (EAEC) useful for diagnosis and therapy of EAEC infections |
| 08/03/2006 | US20060172354 Novel proteins in enteroaggregative Escherichia coli (EAEC) useful for diagnosis and therapy of EAEC infections |
| 08/03/2006 | US20060172353 Diagnosis of candidiasis and candidemia or invasive candida infection |
| 08/03/2006 | US20060172350 identification and characterization of a disease and cancer-associated antigen KID24; antibodies that bind to KID24 |
| 08/03/2006 | US20060172349 LUCA2 and antibodies that bind thereto |
| 08/03/2006 | US20060172348 incubating a cell or tissue sample with a purified antibody or an antigen binding fragment that binds specifically to a portion of human NAIP protein, detecting binding of antibody to such cell or tissue sample |
| 08/03/2006 | US20060172347 Method of diagnosis, treatment and useful agents for conditions characterised by modulation in the level of activin ssc |
| 08/03/2006 | US20060172346 Methods of designing and producing novel compounds having improved binding affinity for CD154 or other trimeric proteins |
| 08/03/2006 | US20060172344 Single chain antibody and use thereof |
| 08/03/2006 | US20060172343 Isolated using polymerase chain reaction using primers ; gene therapy; wound heaaling agents |
| 08/03/2006 | US20060172335 Detection, screening substrate; using enzyme activator;development of therapeytic drugs |
| 08/03/2006 | US20060172327 Sequencing of surface immobilized polymers utilizing microflourescence detection |
| 08/03/2006 | US20060172312 Multi-component inhibitors of nucleic acid polymerases |
| 08/03/2006 | US20060172311 Markers for cardiac disease, sensitive and accurate; expressed in cardiac tissue, as opposed to other types of tissues, optionally and preferably including muscle tissue; measurement of these markers, samples provides information that can correlate with diagnosis of cardiac disease |
| 08/03/2006 | US20060172308 Labeling reagents and labeled targets comprising nonmetallic porphyrins |
| 08/03/2006 | US20060172301 Secreted acid phosphatse (sapm) is present only in pathogenic mycobacteria and expressed selectively at phagosomal ph |
| 08/03/2006 | US20060172298 Denaturat stable and/or protease resistant, chaperone-like oligomeric proteins, polynucleotides encoding same, their uses and methods of increasing a specific activity thereof |
| 08/03/2006 | US20060172291 Polymorphisms in the human gene for cytochrome p450 polypeptide 2c8 and their use in diagnostic and therapeutic applications |
| 08/03/2006 | US20060172287 Murine calicivirus |
| 08/03/2006 | US20060171964 Polypeptides and polynucleotides from coagulase-negative staphylococci |
| 08/03/2006 | US20060171961 A lysine-glycine-lysine-glycine-Xaa pentapeptide residue complexed with one or more B-cell or T-cell determinants and targeting molecules; influenza type A vaccinations |
| 08/03/2006 | US20060171954 Antigen specific activated T-lymphocytes, detection and use |
| 08/03/2006 | US20060171953 Tumour-specific animal proteins |
| 08/03/2006 | US20060171952 JAM-3 and antibodies that bind thereto |
| 08/03/2006 | US20060171951 Monoclonal antibodies that bind to antigen oncostatin M receptor beta subunit (OSM-R.beta); cancers |
| 08/03/2006 | US20060171950 Use of cd23 antagonists for the treatment of neoplastic disorders |
| 08/03/2006 | US20060171942 Modified fusion molecules for treatment of allergic disease |
| 08/03/2006 | US20060171941 Humanized anti-TAG-72 CC49 monoclonal antibodies; retain binding affinity for TAG-72 and have reduced immunogenicity, as compared to a parental HuCC49V10 antibody; carcinoma; antitumor agent |
| 08/03/2006 | US20060171940 Antibody disulfide isomers, use thereof, and methods of analyzing same |
| 08/03/2006 | DE102005002969A1 Verfahren zum Nachweis und zur Entfernung von Endotoxin A method for the detection and removal of endotoxin |
| 08/03/2006 | CA2600111A1 Agent for stimulating the production of a blood coagulation factor viii |
| 08/03/2006 | CA2596276A1 Use of baff to treat th2-mediated conditions |
| 08/03/2006 | CA2595865A1 Immunoassay for prion disease |
| 08/03/2006 | CA2595778A1 Anti-muc1 .alpha..beta. antibodies |
| 08/03/2006 | CA2595682A1 Method for generating variable domain sequences of heavy chain antibodies |
| 08/03/2006 | CA2595380A1 Stabilized liquid polypeptide formulations |
| 08/03/2006 | CA2595377A1 Methods for diagnosis and prognosis of epithelial cancers |
| 08/03/2006 | CA2594502A1 Homogeneous preparations of il-31 |
| 08/03/2006 | CA2590164A1 Antibodies against interleukin-1 beta |
| 08/03/2006 | CA2589860A1 Humanized anti-amyloid antibody |
| 08/02/2006 | EP1686175A2 Proteins and nucleic acids encoding same |
| 08/02/2006 | EP1686174A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 08/02/2006 | EP1686137A1 Method of stabilizing protein solutions |
| 08/02/2006 | EP1686135A1 G protein-coupled receptors |
| 08/02/2006 | EP1685405A1 Angiogenesis inhibiting molecules and their use in the treatment and diagnosis of cancer |
| 08/02/2006 | EP1685248A2 Oxidoreductase from metschnikowia zobellii |
| 08/02/2006 | EP1685245A2 A process of making transgenic mammals that produce exogenous proteins in milk and transgenic mammals produced thereby |
| 08/02/2006 | EP1685236A2 Methods for altering hematopoietic progenitor cell adhesion, differentiation, and migration |
| 08/02/2006 | EP1685161A1 Affinity- plus ion exchange-chromatography for purifying antibodies |
| 08/02/2006 | EP1685159A2 Tim-3 polypeptides |
| 08/02/2006 | EP1685152A2 Il-18 binding proteins |
| 08/02/2006 | EP1684869A2 Methods of therapy for b cell-related cancers |
| 08/02/2006 | EP1684805A2 Use of antagonist anti-cd40 monoclonal antibodies for treatment of multiple myeloma |
| 08/02/2006 | EP1684804A2 Binding molecules for the extra-domain b of fibronectin, used for the detection of atherosclerotic plaques |
| 08/02/2006 | EP1684790A2 Homogeneous preparations of chimeric proteins |
| 08/02/2006 | EP1684770A1 Oligo-beta-(1,3)-glucan and monoclonal antibodies against cancer |
| 08/02/2006 | EP1684703A2 Methods and compositions for treating mcp-1 related pathologies |
| 08/02/2006 | EP1196560B1 Neurotrophic factor receptor gfr-alpha-4 |
| 08/02/2006 | EP1058562B1 Compositions and methods of treating tumors |
| 08/02/2006 | EP0914339B1 RET LIGAND 3 (RetL3) FOR STIMULATING NEURAL AND RENAL GROWTH |
| 08/02/2006 | EP0751962B1 Methods for inhibiting cd14 mediated cell activation |
| 08/02/2006 | EP0737208B1 Monoclonal antibodies specific for phf-tau, hybridomas secreting them, antigen recognition by these antibodies and their applications |
| 08/02/2006 | CN1813188A Diagnosis of carcinomas |
| 08/02/2006 | CN1813066A Novel beta-actin and rps21 promoters and uses thereof |
| 08/02/2006 | CN1813000A Synthetic antibody phage libraries |
| 08/02/2006 | CN1812999A Pharmaceutical composition comprising a bispecific antibody specific for EpCAM |
| 08/02/2006 | CN1810835A Optimization and extraction process of whole length polyclonal rabbit anti-human SMN antibody |
| 08/02/2006 | CN1810292A Protein purification by ion exchange chromatography |
| 08/02/2006 | CN1267553C Haemophilus transferrin receptor genes |
| 08/02/2006 | CN1267550C Vascular endothelial growth factor 2 |
| 08/02/2006 | CN1267452C Monoclonal antibodies, antigens and diagnosis and therapy of malignant diseases |
| 08/01/2006 | US7084260 High affinity human antibodies and human antibodies against human antigens |
| 08/01/2006 | US7084259 G-protein coupled receptors |
| 08/01/2006 | US7084258 Antibodies against the PRO862 polypeptides |
| 08/01/2006 | US7084257 Fully human antibody Fab fragments with human interferon-gamma neutralizing activity |